Anti-convulsants Flashcards
Define seizure
Abnormal neuronal control resulting in dysfunction of motor control, sensory perception, autonomic dysfunction, and behavior changes.
Define epilepsy
Spontaneous, unprovoked seizures separated by 24 hours
Describe the pathophysiology of a seizure
Multiple different mechanisms (ions, neurotransmitter, 2nd messenger) lead to the excess of excitability or the disorder of inhibition. The result is spreading excitability.
Describe the classification of seizures.
Seizures can be classified into broad categories based on region of activity. Partial (focal) or generalized.
Name and describe the 3 types of partial (focal) seizures.
- Simple partial seizures - patient maintains awareness, but there are motor, autonomic, sensory, and behavioral manifestations
- Complex partial seizures - began focally, but progress to widespread; involve the limbic system –> memory loss and abnormal behavior
- Secondarily Generalized - focal onset progresses to generalized tonic-clonic seizure
Describe the generalized tonic-clonic seizure.
Generalized tonic-clonic (grand mal) seizure - begins with tonic contractions, followed by clonic contractions; patient may moan, become incontinent, become cyanotic, or bite tongue; followed by posttictal state (confusion and temporary amnesia)
Describe the absence seizure.
Absence (petit mal) seizure - sudden onset and abrupt cessation of blank state; occurs in young children to adolescence
Describe the myoclonic jerk.
Shock-like muscle contractions of many seizure types
Describe the general treatment approach to seizures.
The goal of therapy is to suppress seizures, not prevent or cure. Compliance is of utmost importance.
Begin with monotherapy at low doses and titrate gradually. If the dosing can’t be increased, switch to another monotherapy before double therapy. The second drug should be titrated before the 1st drug is tapered.
Treatment must be monitored regularly due to narrow therapeutic windows.
What are the common ADRs of anti-epileptic drugs (AEDs)
Sedation, dizziness, ataxia, visual disturbances, and difficulty concentrating
Describe the MOA, uses, unique ADRs, and DDIs (3) of phenytoin
MOA - prolongs Na channel inactivation, inhibits glutamate release, and enhances GABA release
Uses - partial and generalized tonic-clonic
Unique ADRs - Gingival hyperplasia, hirsutism, bradycardia, hypotension, and dysrrhythmias
DDIs - Highly protein bound (displaced by sulfonamides), CYP2C9 inducer (warfarin decreased) and CYP3A4 inducer (decreased oral contraceptives
Describe the MOA, uses, unique ADRs, and DDIs of carbemazepine.
MOA - prolong Na channel inactivation, inhibits glutamate release
Uses - partial, generalized tonic-clonic, and mania of bipolar disorder
Unique ADRs - hyponatremia, blood dyscrasias (aplastic anemia and agranulocytosis, leukopenia, and SJS
DDIs - Potent CYP3A4 inducer –> autoinduction, decreased levels with phenytoinn and phenobarbital; may decrease oral contraceptive; synergistic with valproic acid
Describe the MOA, uses, unique ADRs, and DDIs of phenobarbital.
MOA - enhances GABA-A current and decreases glutamate release
Uses - partial seizures and tonic-clonic seizures
Unique ADRs - none
DDI - potent CYP450 inducer
Note: belongs to the barbituate drug class
Describe the MOA, uses, and unique ADRs of gabapentin.
MOA - binds alpha2delta portion of Ca channels –> decreased calcium conductance and release of glutamate
Uses - partial seizures and generalized tonic-clonic
Unique ADRs - headache and tremors
Describe the MOA, uses, unique ADRs, and DDIs of lamotrigine.
MOA - inactivation of Na and Ca channels
Uses - partial seizures, generalized tonic-clonic seizures, and bipolar disorder
Unique ADRs - skin rash
DDIs - concentration may be reduced by estrogen containing OCPs; may cause failure of progestin-only OCPs